Multicenter, randomised, open-label, non-comparative phase 2 trial on the efficacy and safety of the combination of bevacizumab and trabectedin with or without carboplatin in women with partially platinum-sensitive recurrent ovarian cancer

Nicoletta Colombo, Eleonora Zaccarelli, Alessandra Baldoni, Simona Frezzini, Giovanni Scambia, Eleonora Palluzzi, Germana Tognon, Andrea A Lissoni, Daniela Rubino, Annamaria Ferrero, Gabriella Farina, Emanuele Negri, Angela Pesenti Gritti, Francesca Galli, Elena Biagioli, Eliana Rulli, Davide Poli, Chiara Gerardi, Valter Torri, Roldano FossatiMaurizio D'Incalci

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Multicenter, randomised, open-label, non-comparative phase 2 trial on the efficacy and safety of the combination of bevacizumab and trabectedin with or without carboplatin in women with partially platinum-sensitive recurrent ovarian cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences